Back to search

Article

Molecular Evolutionary Process of Advanced Gastric Cancer During Sequential Chemotherapy Detected by Circulating Tumor DNA

2021-09-01

Abstract excerpt

<h4>Background: </h4> Chemotherapy is the major strategy for advanced gastric cancer (AGC) patients, whereits efficacy has largely plateaued. Tumor evolutionary theory provides a promising strategy to optimize paradigm of cancer treatment, while current data of molecular changes during sequential chemotherapy is too insufficient to understandevolutionary process in tumors. <h4>Methods: </h4>: Here, we performed NG...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
62bd86f6-3c50-5507-9bbe-e6e9c9386e8b
DOI
10.21203/rs.3.rs-823245/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular Evolutionary Process of Advanced Gastric Cancer During Sequential Chemotherapy Detected by Circulating Tumor DNADOI 10.21203/rs.3.rs-823245/v1
Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA.Semantic proximity
Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy.Semantic proximity
Clonal architectures predict clinical outcome in gastric adenocarcinoma based genomic variation and tumor evolution and heterogeneity in gastric adenocarcinomaSemantic proximity
Circulating tumor DNA profiling by next generation sequencing reveals heterogeneity of crizotinib resistance mechanisms in a gastric cancer patient with MET amplification.Semantic proximity
The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitorsSemantic proximity
Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2‐targeted therapiesSemantic proximity
[Application of next-generation sequencing technology detecting ctDNA in the diagnosis and treatment of gastric cancer].Semantic proximity
Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancersSemantic proximity
Circulating tumor DNA predicts clinical benefits of immune checkpoint blockade in HER2-negative patients with advanced gastric cancerSemantic proximity
Circulating tumor DNA functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancerSemantic proximity
First-line pembrolizumab, trastuzumab, and chemotherapy in advanced HER2-positive gastric cancer with sequential genomic profilingSemantic proximity
Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA.Semantic proximity
Select a neighboring publication to make it the new centre.